The P/E ratio for Integra Lifesciences Holdings stock stands at 61.82 as of Jul 25, 2024. This takes into account the latest EPS of $0.51 and stock price of $31.53. An increase of 39% has been observed in the PE ratio compared to its average of 44.4 of the past four quarters.
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 126.84. The current 61.82 price-to-earnings ratio is 51% less than the historical average. Analyzing the last ten years, IART's PE ratio reached its highest point in the Sep 2015 quarter at 1,489, with a price of $29.78 and an EPS of $0.02. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 51.24 | 99.22% |
| 2022 | 25.72 | -23.22% |
| 2021 | 33.5 | -18.47% |
| 2020 | 41.09 | -58.4% |
| 2019 | 98.78 | 59.89% |
| 2018 | 61.78 | 8.42% |
| 2017 | 56.98 | 32.82% |
| 2016 | 42.9 | N/A |
| 2015 | N/A | N/A |
| 2014 | 52.14 | N/A |
The current PE ratio of IART is above its 3 and 5-year averages, but it is under its 10-year average.
When compared to its peer stocks JNJ and SYK, IART's PE ratio is higher. Integra Lifesciences Holdings's current PE ratio of 61.82 is more than the average of its peers, which is 30.0.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| CNMD CONMED Corp | 26.39 | $2.19B |
| MDT Medtronic plc | 28.41 | $100.91B |
| TFX Teleflex Inc | 35.14 | $10.38B |
| SYK Stryker Corp | 37.48 | $126.35B |
| CAH Cardinal Health Inc | 43.14 | $23.95B |
| IART Integra Lifesciences Holdings Corp | 61.67 | $2.48B |
| XRAY DENTSPLY SIRONA Inc | N/A | $5.48B |
As of Jul 25, 2024, IART stock has a price to earnings ratio of 61.82.
Over the last 3 years, the average PE ratio for IART stock is 33.98.
Over the last 5 years, the average PE ratio for IART stock is 48.39.
Over the last ten years, the quarterly PE ratio reached its highest level at 1,489 in the Sep 2015 quarter.
IART's price to earnings ratio is currently 51% below its 10-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Jul 25, 2024), Integra Lifesciences Holdings's share price is $31.53. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.51. Therefore, Integra Lifesciences Holdings's price to earnings ratio for today is 61.82. PE RATIO(61.82) = STOCK PRICE($31.53) / TTM EPS($0.51)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.